In this review, we have highlighted the Bcl-2 family network of proteins in lymphoma, including the recent discovery of BCL-W overexpression in B cell lymphomas, and described current clinical strategies to inhibit anti-apoptotic Bcl-2 family proteins that aim to develop more effective therapies for B cell lymphoma. This evidence concerns the gene BCL2 and lymphoma.